|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.34 USD | +1.76% |
|
+0.74% | -10.35% |
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.39B | 1.58B | 1.86B | 2.15B | 2.54B | |||||
Total Revenues | 1.39B | 1.58B | 1.86B | 2.15B | 2.54B | |||||
Cost of Goods Sold, Total | 292M | 321M | 332M | 324M | 335M | |||||
Gross Profit | 1.1B | 1.26B | 1.53B | 1.83B | 2.2B | |||||
Selling General & Admin Expenses, Total | 1.21B | 1.13B | 1.16B | 1.16B | 1.28B | |||||
R&D Expenses | 557M | 571M | 581M | 637M | 737M | |||||
Other Operating Expenses, Total | 1.76B | 1.71B | 1.74B | 1.8B | 2.02B | |||||
Operating Income | -661M | -446M | -207M | 25.83M | 182M | |||||
Interest Expense, Total | -79.93M | -60.73M | -64.11M | -169M | -11.12M | |||||
Interest And Investment Income | 4.07M | 4.76M | 38.43M | 68.49M | 62.31M | |||||
Net Interest Expenses | -75.87M | -55.97M | -25.69M | -101M | 51.19M | |||||
Currency Exchange Gains (Loss) | -8.9M | -3.2M | -1.6M | -4.3M | -900K | |||||
Other Non Operating Income (Expenses) | -270M | -197M | 851K | -3.69M | -11.18M | |||||
EBT, Excl. Unusual Items | -1.02B | -702M | -233M | -83.05M | 221M | |||||
Restructuring Charges | - | -11.22M | -230K | -16.3M | - | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Asset Writedown | -13K | - | - | - | - | |||||
Legal Settlements | - | - | - | -1.97M | -9.45M | |||||
Other Unusual Items | - | -64.91M | - | - | - | |||||
EBT, Incl. Unusual Items | -1.02B | -778M | -234M | -101M | 212M | |||||
Income Tax Expense | 18.49M | 19.26M | 20.98M | 23.46M | 23.28M | |||||
Earnings From Continuing Operations | -1.03B | -798M | -255M | -125M | 188M | |||||
Net Income to Company | -1.03B | -798M | -255M | -125M | 188M | |||||
Net Income - (IS) | -1.03B | -798M | -255M | -125M | 188M | |||||
Net Income to Common Incl Extra Items | -1.03B | -798M | -255M | -125M | 188M | |||||
Net Income to Common Excl. Extra Items | -1.03B | -798M | -255M | -125M | 188M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -5.01 | -3.62 | -1.09 | -0.51 | 0.7 | |||||
Basic EPS - Continuing Operations | -5.01 | -3.62 | -1.09 | -0.51 | 0.7 | |||||
Basic Weighted Average Shares Outstanding | 206M | 221M | 233M | 245M | 267M | |||||
Net EPS - Diluted | -5.01 | -3.62 | -1.09 | -0.51 | 0.65 | |||||
Diluted EPS - Continuing Operations | -5.01 | -3.62 | -1.09 | -0.51 | 0.65 | |||||
Diluted Weighted Average Shares Outstanding | 206M | 221M | 233M | 245M | 294M | |||||
Normalized Basic EPS | -3.07 | -1.99 | -0.63 | -0.21 | 0.52 | |||||
Normalized Diluted EPS | -3.07 | -1.99 | -0.63 | -0.21 | 0.47 | |||||
Supplemental Items | ||||||||||
EBITDA | -581M | -372M | -140M | 95.64M | 253M | |||||
EBITA | -658M | -444M | -206M | 26.15M | 182M | |||||
EBIT | -661M | -446M | -207M | 25.83M | 182M | |||||
EBITDAR | -539M | -329M | -98M | 134M | 290M | |||||
Total Revenues (As Reported) | 1.39B | 1.58B | 1.86B | 2.15B | 2.54B | |||||
Effective Tax Rate - (Ratio) | -1.82 | -2.48 | -8.98 | -23.15 | 11 | |||||
Current Domestic Taxes | 108K | 90K | 55K | 2.05M | 5.26M | |||||
Current Foreign Taxes | 21.8M | 21.58M | 21.95M | 23.92M | 21.66M | |||||
Total Current Taxes | 21.91M | 21.67M | 22.01M | 25.98M | 26.92M | |||||
Deferred Domestic Taxes | 24K | 23K | 24K | 24K | 24K | |||||
Deferred Foreign Taxes | -3.45M | -2.43M | -1.06M | -2.54M | -3.66M | |||||
Total Deferred Taxes | -3.42M | -2.4M | -1.03M | -2.52M | -3.64M | |||||
Normalized Net Income | -635M | -439M | -146M | -51.9M | 138M | |||||
Interest on Long-Term Debt | 79.93M | 60.73M | 64.11M | 169M | 7.63M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 22.1M | 13.7M | 11.6M | 14.7M | 15.6M | |||||
Selling and Marketing Expenses | 1.05B | 968M | 925M | 964M | 1.06B | |||||
General and Administrative Expenses | 154M | 166M | 232M | 199M | 228M | |||||
Research And Development Expense From Footnotes | 557M | 572M | 581M | 639M | 737M | |||||
Net Rental Expense, Total | 42.6M | 43.3M | 42.4M | 38.6M | 37.7M | |||||
Imputed Operating Lease Interest Expense | 29.66M | 15.97M | 15.69M | 51.66M | 3.07M | |||||
Imputed Operating Lease Depreciation | 12.94M | 27.33M | 26.71M | -13.06M | 34.63M | |||||
Stock-Based Comp., COGS (Total) | 30.48M | 38.22M | 34.58M | 34.11M | 30.41M | |||||
Stock-Based Comp., R&D Exp. (Total) | 151M | 144M | 139M | 157M | 175M | |||||
Stock-Based Comp., S&M Exp. (Total) | 123M | 105M | 82.76M | 80.19M | 80.93M | |||||
Stock-Based Comp., G&A Exp. (Total) | 54.39M | 56.67M | 55.34M | 62.75M | 64.89M | |||||
Total Stock-Based Compensation | 359M | 343M | 312M | 334M | 352M |
- Stock Market
- Equities
- NTNX Stock
- Financials Nutanix, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















